Specialized Disclosure Report (sd)
May 31 2018 - 4:30PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form SD
S
PECIALIZED
D
ISCLOSURE REPORT
GenMark Diagnostics, Inc.
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
001-34753
|
|
27-2053069
|
(State or Other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification Number)
|
|
|
|
|
|
|
|
5964 La Place Court
Carlsbad, California
|
|
92008
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
|
|
|
|
Eric Stier
760-448-4300
|
|
(Name and telephone number, including area code, of the person to contact in connection with this report.)
|
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
ý
Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2017.
Section 1 - Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure and Report
The Conflict Minerals Report of GenMark Diagnostics, Inc. (the “Company”) for the calendar year ended December 31, 2017 is filed as Exhibit 1.01 hereto and is publicly available at
http://ir.genmarkdx.com
under the “Corporate Governance” heading. The foregoing website and the information accessible through it are not incorporated into this report.
Item 1.02 Exhibits
The Company is filing its Conflict Minerals Report as Exhibit 1.01 to this report.
Section 2 - Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
GenMark Diagnostics, Inc.
(Registrant)
|
|
|
|
|
|
|
/s/ Eric Stier
|
|
|
|
|
By:
|
Eric Stier
|
Title:
|
Senior Vice President, General Counsel & Secretary
|
|
|
|
May 31, 2018
|
|
|
|
|
|
|
|
|
|
|
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Mar 2024 to Apr 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Apr 2023 to Apr 2024